Skip to content

Montana · Nonprofit

MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC

MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC (Montana) receives grants from 13 organizations whose IRS filings report $7,751,673 to it, the largest being DONOR ADVISED CHARITABLE GIVING INC ($6,057,000). 10 of them have funded it in more than one year, and 93% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2024
$3.9M
Funders on record
13
Grants received
$7.8M
Net assets
$14M
10/13 repeat funderspeak grant-dependency 68%
01What it does

What McLaughlin Research Institute for Biomedical Sciences Inc does

Mission

The institute's mission is to improve human health through innovative genetic research and education. Research at the institute focuses on understanding the genetic control of normal development and susceptibility to neurological diseases using the mouse as the model system. The institute also offers research internships for students and teachers.

As stated on its FY2024 Form 990.

Programs

  1. During fiscal year 2024, the institute scientists and staff continued their efforts to better understanding the cellular and molecular mechanisms of neurodegenerative disease processes through innovative genetic approaches in murine models while expanding the program of translational research to supplement treatment advances and education through community engagement with student internships. The research focused largely on the mechanisms behind the propagation of protein misfolding in diseases such as frontotemporal dementia, alzheimer's and prion diseases, as well as novel treatment approaches. Such work included partnerships with up to 11 collaborators and 20 projects among investigators with partnerships extending nationally to new york, massachusetts, north carolina and california which resultant subawards contributed to $712,800 of nih grant fund support and $307,000 in research contracts. Efforts continued towards understanding alzheimer's disease with partners at columbia university and wake forest university; prion diseases with partners at the broad at harvard university & prion alliance. Investigators continued critical work on novel treatment development screening…

    $4,175,957 spent$313,640 earned by the program
    99% of program spending
  2. The institute hosted another busy and successful summer internship program distributing a total of $31,050 in scholarships to high school and college students for 8-weeks of bench side research & presentation. Medical students from neighboring touro college of osteopathic medicine (mt) joined the research efforts through temporary positions as well as first rotation of four students in the medical scientist training program.

    $31,050 spentof which $31,050 as grants
    1% of program spending

The 2 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $4,207,007.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

100 = 20172017 Revenue 100 ($1.9M) Expenses 100 ($2.6M) Net assets 100 ($12M)2018 Revenue 68 ($1.3M) Expenses 86 ($2.3M) Net assets 92 ($11M)2019 Revenue 82 ($1.5M) Expenses 81 ($2.1M) Net assets 86 ($11M)2020 Revenue 154 ($2.9M) Expenses 81 ($2.1M) Net assets 84 ($11M)2021 Revenue 198 ($3.7M) Expenses 90 ($2.4M) Net assets 101 ($13M)2022 Revenue 409 ($7.6M) Expenses 141 ($3.7M) Net assets 123 ($15M)2023 Revenue 129 ($2.4M) Expenses 164 ($4.3M) Net assets 111 ($14M)2024 Revenue 208 ($3.9M) Expenses 184 ($4.8M) Net assets 110 ($14M)
'17'18'19'20'21'22'23'24
Revenue (208)Expenses (184)Net assets (110)

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $14M to $11M (−21%).

$13M
$14M
$11M
$11M
$13M
$16M
$14M
$14M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 23% · 2018 36% · 2019 26% · 2020 15% · 2021 15% · 2022 3% · 2023 60% · 2024 65%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.

−$749k
’17
−$989k
’18
−$609k
’19
$752k
’20
$1.3M
’21
$3.9M
’22
−$1.9M
’23
−$922k
’24
1.4
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Randy Gray

Chairman

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed1618181414181718
Joined·+2+1+1+1+4+1+2
No longer listed·0151021
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 3 funders to 8 funders, grant income rose $81k → $437k.

5 of 13 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 93% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC leans on a few funders — its largest provides 78% of grant income and the top three 98%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

98% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC.

78%
largest funder
98%
top three
~2
effective funders

Largest funder’s share by year: 2017 93% · 2018 92% · 2019 92% · 2020 80% · 2021 75% · 2022 97% · 2023 49% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

75% of MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC's funders are still giving 3 years after their first grant; 77% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

93% of MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $512k that is directly attributable, 88% of it comes from funders outside Montana, across 4 states.

MT
MA
WY
DE

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Montana out of state home

Funder states come from each funder’s own filing. $7.2M arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Government funding MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $14.8M on record.

Federal$14.8M
grants $14.7Mcontracts $31k
18
19
20
21
22
23
24
25
26
Top agencies
  • Department of Health and Human Services$14.7M
  • Department of Veterans Affairs$31k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Montana

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

87% of spending goes to programs.

Program 87%Management 11%Fundraising 1%

Governance

13
board members
92%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention–Board reviewed the 990✓Audited financials

Public support

52%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Part of a family of 1 related entity

  • Lewis and Clark Biologicals Inc · corp_trust

Screen this organization

A dated, signed PDF of the compliance screen for MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC?
MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC (Montana) receives grants from 13 organizations whose IRS filings report $7,751,673 to it, the largest being DONOR ADVISED CHARITABLE GIVING INC ($6,057,000). 10 of them have funded it in more than one year, and 93% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC have?
IRS filings report 13 organizations giving $7,751,673 in grants to MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC, 10 of which have funded it in more than one year.
Who is the largest funder of MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC?
DONOR ADVISED CHARITABLE GIVING INC is the largest funder on record, with $6,057,000 in grants. The full list of funders is on this page.
How can an organization like MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Montana. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 13 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing